Takayuki Ito

4.6k total citations
104 papers, 3.3k citations indexed

About

Takayuki Ito is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Takayuki Ito has authored 104 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 38 papers in Molecular Biology and 21 papers in Physiology. Recurrent topics in Takayuki Ito's work include Nitric Oxide and Endothelin Effects (15 papers), Cardiac Imaging and Diagnostics (13 papers) and Inflammatory mediators and NSAID effects (13 papers). Takayuki Ito is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Cardiac Imaging and Diagnostics (13 papers) and Inflammatory mediators and NSAID effects (13 papers). Takayuki Ito collaborates with scholars based in Japan, United States and United Kingdom. Takayuki Ito's co-authors include Kenji Okumura, Uichi Ikeda, Yukio Toki, Tetsuo Hayakawa, Hideo Matsui, Tatsuo Satake, Itsuro Morishima, Hidekazu Hashimoto, Takayuki Ozawa and Kouichi Ogawa and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Takayuki Ito

101 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takayuki Ito Japan 32 1.2k 1.2k 653 637 405 104 3.3k
Peter Hansell Sweden 30 1.1k 0.9× 472 0.4× 504 0.8× 714 1.1× 442 1.1× 157 4.2k
Hideharu Hayashi Japan 31 1.5k 1.2× 1.1k 1.0× 298 0.5× 542 0.9× 258 0.6× 142 3.0k
David Montaigne France 30 1.1k 0.9× 1.6k 1.4× 547 0.8× 414 0.6× 322 0.8× 106 3.4k
Victor G. Sharov United States 37 1.9k 1.6× 2.8k 2.4× 796 1.2× 636 1.0× 339 0.8× 85 4.8k
Satoshi Ogawa Japan 24 1.4k 1.2× 582 0.5× 302 0.5× 580 0.9× 123 0.3× 40 3.5k
Travis W. Hein United States 32 992 0.8× 1.1k 0.9× 370 0.6× 1.6k 2.5× 414 1.0× 87 3.6k
Paolo Mené Italy 30 1.3k 1.1× 628 0.5× 397 0.6× 823 1.3× 88 0.2× 133 3.4k
R A Kelly United States 35 2.0k 1.6× 1.9k 1.6× 432 0.7× 2.0k 3.1× 118 0.3× 47 4.7k
Hozuka Akita Japan 27 658 0.6× 915 0.8× 412 0.6× 754 1.2× 182 0.4× 79 2.4k
Gorka San José Spain 30 758 0.6× 1.3k 1.1× 407 0.6× 906 1.4× 127 0.3× 51 3.1k

Countries citing papers authored by Takayuki Ito

Since Specialization
Citations

This map shows the geographic impact of Takayuki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayuki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayuki Ito more than expected).

Fields of papers citing papers by Takayuki Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayuki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayuki Ito. The network helps show where Takayuki Ito may publish in the future.

Co-authorship network of co-authors of Takayuki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Takayuki Ito. A scholar is included among the top collaborators of Takayuki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayuki Ito. Takayuki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kitamura, Hiroshi, et al.. (2025). JAVEMACS-D: claims database analysis of avelumab maintenance therapy for advanced urothelial carcinoma in Japan. Scientific Reports. 15(1). 41773–41773.
2.
Kato, Taigo, Junya Furukawa, Nobuyuki Hinata, et al.. (2024). Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. International Journal of Clinical Oncology. 30(1). 99–109. 2 indexed citations
3.
Ozawa, Keiya, Kazuya Sato, Iekuni Oh, et al.. (2008). Cell and gene therapy using mesenchymal stem cells (MSCs). Journal of Autoimmunity. 30(3). 121–127. 127 indexed citations
4.
Mukawa, Hiroaki, Yukio Toki, Yutaka Miyazaki, et al.. (2003). Angiotensin II Type 2 Receptor Blockade Partially Negates Antihypertrophic Effects of Type 1 Receptor Blockade on Pressure-Overload Rat Cardiac Hypertrophy.. Hypertension Research. 26(1). 89–95. 20 indexed citations
5.
Ito, Takayuki, Uichi Ikeda, Masahisa Shimpo, et al.. (2002). HMG-CoA Reductase Inhibitors Reduce Interleukin-6 Synthesis in Human Vascular Smooth Muscle Cells. Cardiovascular Drugs and Therapy. 16(2). 121–126. 43 indexed citations
6.
Ito, Takayuki, Uichi Ikeda, Keiji Yamamoto, & Kazuyuki Shimada. (2002). Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells. Atherosclerosis. 165(1). 51–55. 42 indexed citations
7.
Numaguchi, Yasushi, Hideo Matsui, Yukio Toki, et al.. (2001). Altered Expression of Prostacyclin Synthase in a Subset of the Thick Ascending Limb Cells and Mesangial Cells in 5/6-Nephrectomized Rats.. Hypertension Research. 24(4). 411–419. 9 indexed citations
8.
Noda, Toshiyuki, Shinya Minatoguchi, Kenshi Fujii, et al.. (1999). Evidence for the delayed effect in human ischemic preconditioning. Journal of the American College of Cardiology. 34(7). 1966–1974. 55 indexed citations
9.
Toki, Yukio, Yasushi Numaguchi, Hiroaki Mukawa, et al.. (1998). Nitroglycerin-induced aortic relaxation mediated by calcium-activated potassium channel is markedly diminished in hypertensive rats. Life Sciences. 63(12). 1047–1055. 14 indexed citations
10.
11.
Toki, Yukio, et al.. (1997). Role of K+ channels in EDHF-dependent relaxation induced by acetylcholine in canine coronary artery. Heart and Vessels. 12(6). 287–293. 15 indexed citations
12.
Okumura, Kenji, et al.. (1995). Abnormal arachidonate distribution in low-density lipoprotein and thoracic aorta in hyperinsulinemia. Metabolism. 44(6). 806–811. 4 indexed citations
13.
Shimizu, Kiyokazu, Hiroshi Asano, Yukio Toki, et al.. (1993). Role of Prostaglandin H2 as an Endothelium-Derived Contracting Factor in Diabetic State. Diabetes. 42(9). 1246–1252. 66 indexed citations
14.
Hattori, Kazuki, Masashi Tanaka, Satoru Sugiyama, et al.. (1991). Age-dependent increase in deleted mitochondrial DNA in the human heart: Possible contributory factor to presbycardia. American Heart Journal. 121(6). 1735–1742. 217 indexed citations
15.
Kondo, Junichiro, et al.. (1990). Norepinephrine-induced 1,2-diacylglycerol accumulation and change in its fatty acid composition in the isolated perfused rat heart. Molecular and Cellular Biochemistry. 93(2). 173–8. 4 indexed citations
16.
Kobayashi, Akira, Noboru Yamazaki, Tadashi Kobayashi, et al.. (1990). Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.. Japanese Circulation Journal. 54(12). 1486–1496. 1 indexed citations
17.
18.
Okumura, Kenji, Yumiko Yamada, Junichiro Kondo, et al.. (1988). Increased 1,2-diacylglycerol content in myopathic hamster hearts at a prenecrotic stage. Life Sciences. 43(17). 1371–1377. 10 indexed citations
19.
Ogawa, Kouichi, et al.. (1982). Effects of peripheral vasodilation caused by Verapamil, nifedipine, and nitroglycerin on plasma prostaglandins and thromboxane concentrations.. Japanese Heart Journal. 23(6). 941–949. 12 indexed citations
20.
Kojima, Masaharu, et al.. (1975). New adrenal-scanning agent.. PubMed. 16(7). 666–8. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Hansell Breakdown of academic impact, for papers by Hideharu Hayashi Breakdown of academic impact, for papers by David Montaigne Breakdown of academic impact, for papers by Victor G. Sharov Breakdown of academic impact, for papers by Satoshi Ogawa Breakdown of academic impact, for papers by Travis W. Hein Breakdown of academic impact, for papers by Paolo Mené Breakdown of academic impact, for papers by R A Kelly Breakdown of academic impact, for papers by Hozuka Akita Breakdown of academic impact, for papers by Gorka San José
Rankless by CCL
2026